Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.6.1.2 (
guanylate cyclase
)
8,497
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The research described here provides one mechanism of uniting current effects of nitric oxide (NO) with the elevated levels of homocysteine detected in patients with cardiovascular and other disease. Time- and dose-dependent studies of the inhibition of purified mammalian
methionine synthase
by NO were performed. The in vitro study gave an effective IC50 value of 3 mu mol L-1. Methionine synthase converts cellular homocysteine to methionine and is a major enzyme in the biosynthetic pathways for folates, S-adenosylmethionine and biological methylations, sulphur amino acids and polyamines. Nitric oxide-induced inactivation of
methionine synthase
alters the levels of these metabolites and could therefore provide a connection between the cardiovascular effects of NO, the plasma homocysteine levels and cardiovascular diseases that is complementary to the more traditional NO-induced stimulation of
guanylate cyclase
and the convertion of homocysteine to oxidized sulphur amino acids.
...
PMID:In vitro inactivation of mammalian methionine synthase by nitric oxide. 890 27